| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Benjamin Theurer downgrades Ingredion (NYSE:INGR) from Overweight to Equal-Weight and lowers the price targ...
UBS analyst Joshua Spector maintains Ingredion (NYSE:INGR) with a Neutral and lowers the price target from $130 to $119.
Stephens & Co. analyst Pooran Sharma maintains Ingredion (NYSE:INGR) with a Equal-Weight and lowers the price target fro...
BMO Capital analyst Andrew Strelzik maintains Ingredion (NYSE:INGR) with a Market Perform and lowers the price target from $...
Ingredion (NYSE:INGR) lowers FY2025 GAAP EPS guidance from $11.25-$11.75 to $11.11-$11.31 vs $11.48 analyst estimate..
Ingredion (NYSE:INGR) narrows FY2025 Adj EPS guidance from $11.10-$11.60 to $11.10-$11.30 vs $11.37 analyst estimate..
Ingredion (NYSE:INGR) reported quarterly earnings of $2.75 per share which missed the analyst consensus estimate of $2.89 by 4....
UBS analyst Joshua Spector maintains Ingredion (NYSE:INGR) with a Neutral and lowers the price target from $144 to $130.